{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:45:36Z","timestamp":1773938736662,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.prro.2017.02.001","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T04:47:16Z","timestamp":1486615636000},"page":"e323-e329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gallbladder toxicity and high-dose ablative-intent radiation for liver tumors: Should we constrain the dose?"],"prefix":"10.1016","volume":"7","author":[{"given":"Shyam K.","family":"Tanguturi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Niemierko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Y.","family":"Wo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khanhnhat N.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh","family":"Prichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew X.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2017.02.001_bb0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/0972-9941.16527","article-title":"Anatomy relevant to cholecystectomy","volume":"1","author":"Nagral","year":"2005","journal-title":"J Minim Access Surg"},{"key":"10.1016\/j.prro.2017.02.001_bb0010","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1634\/theoncologist.2014-0097","article-title":"Radiation therapy for liver tumors: Ready for inclusion in guidelines?","volume":"19","author":"Tanguturi","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.prro.2017.02.001_bb0015","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1200\/JCO.2014.55.4675","article-title":"Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice","volume":"32","author":"Timmerman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2017.02.001_bb0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3748\/wjg.v17.i3.397","article-title":"Adjuvant radiotherapy for gallbladder cancer: A dosimetric comparison of conformal radiotherapy and intensity-modulated radiotherapy","volume":"17","author":"Sun","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.prro.2017.02.001_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.radonc.2009.02.015","article-title":"Image-guided intensity-modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas: Initial clinical results","volume":"92","author":"Fuller","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2017.02.001_bb0030","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/1097-0142(19860201)57:3<536::AID-CNCR2820570322>3.0.CO;2-L","article-title":"Intraluminal radiation therapy in the management of malignant biliary obstruction","volume":"57","author":"Molt","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2017.02.001_bb0035","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2017.02.001_bb0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2017.02.001_bb0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2017.02.001_bb0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1118\/1.1639993","article-title":"4D-CT imaging of a volume influenced by respiratory motion on multi-slice CT","volume":"31","author":"Pan","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2017.02.001_bb0055","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.ijrobp.2004.11.037","article-title":"Four-dimensional image-based treatment planning: Target volume segmentation and dose calculation in the presence of respiratory motion","volume":"61","author":"Rietzel","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2017.02.001_bb0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0360-3016(01)01453-5","article-title":"Organ motion and its management","volume":"50","author":"Langen","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2017.02.001_bb0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1118\/1.598063","article-title":"Reporting and analyzing dose distributions: A concept of equivalent uniform dose","volume":"24","author":"Niemierko","year":"1997","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2017.02.001_bb0070","first-page":"115","article-title":"A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy","volume":"23","author":"Gay","year":"2007","journal-title":"Phytopathol Mediterr"},{"key":"10.1016\/j.prro.2017.02.001_bb0075","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/0360-3016(89)90972-3","article-title":"Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method","volume":"16","author":"Kutcher","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2017.02.001_bb0080","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2017.02.001_bb0085","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1080\/02841860600936369","article-title":"Individualized image guided iso-NTCP based liver cancer SBRT","volume":"45","author":"Dawson","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2017.02.001_bb0095","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.prro.2013.06.004","article-title":"Upper abdominal normal organ contouring guidelines and atlas: A Radiation Therapy Oncology Group consensus","volume":"4","author":"Jabbour","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2017.02.001_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.prro.2013.06.004","article-title":"Upper abdominal normal organ contouring guidelines and atlas: A Radiation Therapy Oncology Group consensus","volume":"4","author":"Jabbour","year":"2014","journal-title":"Pract Radiat Oncol."},{"key":"10.1016\/j.prro.2017.02.001_bb0105","series-title":"Radiobiology for the Radiologist","author":"Hall","year":"2012"},{"key":"10.1016\/j.prro.2017.02.001_bb0110","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","article-title":"American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy","volume":"76","author":"Potters","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2017.02.001_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.semradonc.2006.11.009","article-title":"Normal tissue tolerance dose metrics for radiation therapy of major organs","volume":"17","author":"Milano","year":"2007","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.prro.2017.02.001_bb0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.prro.2013.07.007","article-title":"Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy","volume":"4","author":"Yoon","year":"2014","journal-title":"Pract Radiat Oncol."},{"key":"10.1016\/j.prro.2017.02.001_bb0125","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ijrobp.2009.02.027","article-title":"Chest wall volume receiving >30 Gy predicts risk of severe pain and\/or rib fracture after lung stereotactic body radiotherapy","volume":"76","author":"Dunlap","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2017.02.001_bb0130","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ijrobp.2010.12.002","article-title":"Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT)","volume":"82","author":"Stephans","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2017.02.001_bb0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.prro.2016.05.009","article-title":"Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractions","volume":"7","author":"Swanick","year":"2017","journal-title":"Pract Radiat Oncol."},{"key":"10.1016\/j.prro.2017.02.001_bb0140","doi-asserted-by":"crossref","first-page":"e94859","DOI":"10.1371\/journal.pone.0094859","article-title":"Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry","volume":"9","author":"Coroller","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prro.2017.02.001_bb0145","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ijrobp.2012.09.012","article-title":"Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system","volume":"85","author":"Eriguchi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2017.02.001_bb0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.radonc.2009.11.004","article-title":"Stereotactic body radiotherapy for unresectable cholangiocarcinoma","volume":"94","author":"Kopek","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2017.02.001_bb0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1748-717X-7-67","article-title":"Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma","volume":"7","author":"Barney","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2017.02.001_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2014.11.028","article-title":"Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract","volume":"91","author":"Osmundson","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2017.02.001_bb0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2017.02.001_bb0170","first-page":"35","article-title":"Tolerance of normal tissue to therapeutic radiation","volume":"1","author":"Emami","year":"2013","journal-title":"Rep Radiother Oncol"},{"key":"10.1016\/j.prro.2017.02.001_bb0175","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1002\/cncr.25997","article-title":"Stereotactic body radiotherapy for colorectal liver metastases: A pooled analysis","volume":"117","author":"Chang","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2017.02.001_bb0180","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semradonc.2008.04.005","article-title":"The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery","volume":"18","author":"Kirkpatrick","year":"2008","journal-title":"Semin Radiat Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850017300425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850017300425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:20:02Z","timestamp":1761819602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850017300425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1879850017300425"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2017.02.001","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gallbladder toxicity and high-dose ablative-intent radiation for liver tumors: Should we constrain the dose?","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2017.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}